A Recombinant Antibody to EphA3 with Pro-Apoptotic and Enhanced ADCC Activity Against Various Hematologic Malignancies Shows Selective Inhibition of Colony Formation From Long-Term Culture-Initiating Cells (LTC-ICs) In Primary Leukemia Samples
Varghese Palath(Sunesis (United States)), Christopher Bebbington(Curtin University), David Martínez(Hospital General Universitario Gregorio Marañón), Christina Yi(Sunesis (United States)), Wendy Ching(Sunesis (United States)), Daniela Cilloni(University of Turin), Nenad Tomašević(Regenxbio (United States)), John Leung(Tufts University), Swathi Bhaskar, Andrew M. Scott(Olivia Newton-John Cancer Wellness & Research Centre), Martin Lackmann(Monash University), Rohini Vekhande, Andy Boyd(The University of Texas at San Antonio Health Science Center), Ling Zhang(Hebei Medical University), Mark Baer, Geoffrey Yarranton, Kenneth R. Luehrsen, Alan F. List(TE Laboratories (Ireland)), J.C. Williams(Allakos (United States))
Cited by 6
Related Papers
Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation.
|Journal of Clinical Oncology|1997|1.3k
Azacitidine Prolongs Overall Survival Compared With Conventional Care Regimens in Elderly Patients With Low Bone Marrow Blast Count Acute Myeloid Leukemia
|Journal of Clinical Oncology|2009|963
Efficacy of Lenalidomide in Myelodysplastic Syndromes
|New England Journal of Medicine|2005|874
Levofloxacin to Prevent Bacterial Infection in Patients with Cancer and Neutropenia
|New England Journal of Medicine|2005|644
Chimeric Receptors Providing Both Primary and Costimulatory Signaling in T Cells from a Single Gene Product
|The Journal of Immunology|1998|546